Boxitinib Hydrochloride
盐酸博昔替尼
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameBoxitinib Hydrochloride
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHec Pharm Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesHec Pharm Co Ltd
Inactive CompaniesN/A
Active Indications +[5]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A